These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15886157)

  • 41. Exclusive contracts in the hospital setting: a two-edged sword, part 1: legal issues.
    Portman RM
    J Am Coll Radiol; 2007 May; 4(5):305-12. PubMed ID: 17467613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Programs and policies that promote positive youth development and prevent risky behaviors: an international perspective.
    Naudeau S; Cunningham W; Lundberg MK; McGinnis L;
    New Dir Child Adolesc Dev; 2008; 2008(122):75-87. PubMed ID: 19021247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Commentary: From scarcity to abundance: pandemic vaccines and other agents for "have not" countries.
    Fedson DS; Dunnill P
    J Public Health Policy; 2007; 28(3):322-40. PubMed ID: 17717543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "No Regrets" Purchasing in a pandemic: making the most of advance purchase agreements.
    Thornton I; Wilson P; Gandhi G
    Global Health; 2022 Jun; 18(1):62. PubMed ID: 35715814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):148-51. PubMed ID: 18272957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 48. Global trade, public health, and health services: stakeholders' constructions of the key issues.
    Waitzkin H; Jasso-Aguilar R; Landwehr A; Mountain C
    Soc Sci Med; 2005 Sep; 61(5):893-906. PubMed ID: 15955394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.
    Andrus JK; Sherris J; Fitzsimmons JW; Kane MA; Aguado MT
    Vaccine; 2008 Aug; 26 Suppl 10():K87-92. PubMed ID: 18847561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. US drug companies announce vaccine initiative.
    Ciment J
    BMJ; 2000 Mar; 320(7237):736. PubMed ID: 10720352
    [No Abstract]   [Full Text] [Related]  

  • 51. Prospects for a group A streptococcal vaccine: rationale, feasibility, and obstacles--report of a National Institute of Allergy and Infectious Diseases workshop.
    Bisno AL; Rubin FA; Cleary PP; Dale JB;
    Clin Infect Dis; 2005 Oct; 41(8):1150-6. PubMed ID: 16163634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A real shot.
    Diamond B
    Nat Med; 2005 Apr; 11(4 Suppl):S3-4. PubMed ID: 15812487
    [No Abstract]   [Full Text] [Related]  

  • 53. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 54. Establishing government-operated vaccine programs: an industry perspective.
    Paradiso PR
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S118-20. PubMed ID: 16447132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health innovation networks to help developing countries address neglected diseases.
    Morel CM; Acharya T; Broun D; Dangi A; Elias C; Ganguly NK; Gardner CA; Gupta RK; Haycock J; Heher AD; Hotez PJ; Kettler HE; Keusch GT; Krattiger AF; Kreutz FT; Lall S; Lee K; Mahoney R; Martinez-Palomo A; Mashelkar RA; Matlin SA; Mzimba M; Oehler J; Ridley RG; Senanayake P; Singer P; Yun M
    Science; 2005 Jul; 309(5733):401-4. PubMed ID: 16020723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The United States pediatric vaccine stockpile program.
    Lane KS; Chu SY; Santoli JM
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S125-9. PubMed ID: 16447134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccines--why the US government must act.
    Miller HI
    Nat Biotechnol; 2005 Mar; 23(3):287. PubMed ID: 15765077
    [No Abstract]   [Full Text] [Related]  

  • 59. Are advance market commitments for drugs a real advance?
    Scudellari M
    Nat Med; 2011 Feb; 17(2):139. PubMed ID: 21297588
    [No Abstract]   [Full Text] [Related]  

  • 60. Low-income countries. A boost for vaccine development.
    Travis J
    Science; 2009 Sep; 325(5947):1489. PubMed ID: 19762619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.